Amedeo Smart

Free Medical Literature Service

 

Amedeo

Diabetes
  Free Subscription

Articles published in
Retina
    August 2026
  1. YUN JS, NaPier E, Hosseini H, Au AC, et al
    Vitrectomy for Proliferative Diabetic Retinopathy with Asteroid Hyalosis: Contemporary Outcomes and Challenges.
    Retina. 2026 Aug 6. doi: 10.1097/IAE.0000000000004952.
    >> Share

    July 2026
  2. BADDAR D, Fouad Y, Salem NO, Feo A, et al
    Type 4 macular neovascularization in eyes with diabetic retinopathy.
    Retina. 2026 Jul 30. doi: 10.1097/IAE.0000000000004948.
    >> Share

  3. HIROSAWA K, Inomata T, Nagino K, Sung J, et al
    Ultra-widefield color fundus images and artificial intelligence for diagnosis of diabetic retinopathy: A systematic review and meta-analysis.
    Retina. 2026 Jul 24. doi: 10.1097/IAE.0000000000004939.
    >> Share

  4. ENGIN CD, Selver MA, Koksaldi S, Kayabasi M, et al
    GENERALIZABILITY OF DEEP LEARNING MODELS FOR REFERABLE DIABETIC RETINOPATHY DETECTION: A CROSS-POPULATION STUDY.
    Retina. 2026 Jul 21. doi: 10.1097/IAE.0000000000004924.
    >> Share

  5. ZHAO J, Zhang Y, Miao Y, Shi W, et al
    Enhancing the performance of diabetic retinopathy grading models using synthetic images.
    Retina. 2026 Jul 21. doi: 10.1097/IAE.0000000000004919.
    >> Share

  6. LISHINSKY-FISCHER N, Levy J
    PROSTACYCLIN ANALOGS AND DIABETIC RETINOPATHY OUTCOMES IN PATIENTS WITH PULMONARY HYPERTENSION : A Cohort Analysis.
    Retina. 2026;46:1251-1257.
    >> Share

  7. SATHER RN 3RD, Chiang T, Moon JY, Dev S, et al
    REAL-WORLD DURABILITY OF AFLIBERCEPT 8 MG AND FARICIMAB IN INITIATORS VERSUS SWITCHERS: A Multicenter Retrospective Analysis.
    Retina. 2026;46:1231-1240.
    >> Share

    June 2026
  8. TORRES-VILLAROS H, Lachiver L, Fajnkuchen F, Morel JB, et al
    Severe retinal non-perfusion is associated with fewer retinal lesions on ultra-wide field fundus photography in proliferative diabetic retinopathy.
    Retina. 2026 Jun 23. doi: 10.1097/IAE.0000000000004912.
    >> Share

  9. ALSHAIKHSALAMA AM, Abdi A, Talapathy T, Kim JE, et al
    Diabetic Retinopathy Outcomes Among Unhoused Individuals: A Big Data Analysis.
    Retina. 2026 Jun 9. doi: 10.1097/IAE.0000000000004904.
    >> Share

  10. KIM SJ, Gangaputra S, Choi L, McNeer E, et al
    Inflammatory Mediators in Diabetic Macular Edema: A Prospective, Controlled Study.
    Retina. 2026 Jun 5. doi: 10.1097/IAE.0000000000004893.
    >> Share

    May 2026
  11. ZAFAR S, Momenaei B, Kim I, Cheslow L, et al
    Factors associated with persistent vision loss in eyes with diabetic macular edema and non-proliferative diabetic retinopathy after lost-to-follow-up.
    Retina. 2026 May 29. doi: 10.1097/IAE.0000000000004892.
    >> Share

  12. DEMIREL S, Yanik O, Batioglu F, Dalva K, et al
    Inflammatory and Imaging Biomarkers in Treatment-Naive Diabetic Macular Edema: Comparison with Irvine-Gass and Cataract Controls.
    Retina. 2026 May 26. doi: 10.1097/IAE.0000000000004845.
    >> Share

    April 2026
  13. LI B, Li S, Cun Y
    THE EFFICACY AND SAFETY OF SUBRETINAL BALANCED SALT SOLUTION INJECTION IN DIABETIC MACULAR EDEMA WITH HARD EXUDATES: ERRATUM.
    Retina. 2026 Apr 28. doi: 10.1097/IAE.0000000000004869.
    >> Share

  14. ZHANG C, Bhatnagar A, Ersan S, Smiddy WE, et al
    Trends in the Management of Proliferative Diabetic Retinopathy in the First Year After Diagnosis.
    Retina. 2026 Apr 15. doi: 10.1097/IAE.0000000000004861.
    >> Share

  15. DAI Z, Fan W, Yao Q, Liu K, et al
    Loss to Follow-Up in Patients with Proliferative Diabetic Retinopathy after Pars Plana Vitrectomy.
    Retina. 2026 Apr 15. doi: 10.1097/IAE.0000000000004859.
    >> Share

  16. KIM IP, Orndahl C, Nyaiburi C, Anand R, et al
    Dexamethasone implant and aflibercept combination therapy versus aflibercept monotherapy for diabetic macular edema: A prospective, comparative trial (COED trial).
    Retina. 2026 Apr 9. doi: 10.1097/IAE.0000000000004858.
    >> Share

  17. MIHARA N, Funatsu R, Sonoda S, Sakono T, et al
    A New Technique Using Ultra-Widefield Camera for Improved Neovascularization Detection in Diabetic Retinopathy.
    Retina. 2026 Apr 9. doi: 10.1097/IAE.0000000000004857.
    >> Share

  18. BUTT AB, Ahmed F, Mihalache A, Huang RS, et al
    SOCIODEMOGRAPHIC FACTORS AS PREDICTORS OF DIABETIC RETINOPATHY SCREENING: A Systematic Review.
    Retina. 2026;46:630-653.
    >> Share

    March 2026
  19. GOBLIRSCH TJ, Yu Y, Cardillo S, Hubbard RA, et al
    Racial and Ethnic Differences in Prevalence and Incidence of Diabetic Retinal Disease.
    Retina. 2026 Mar 31. doi: 10.1097/IAE.0000000000004836.
    >> Share

  20. OLIVERIO GW, Meduri A, Ingrande I, Aragona P, et al
    EFFICACY OF COMBINED DEXAMETHASONE IMPLANT AND NAVIGATED SUBTHRESHOLD MICROPULSE YELLOW LASER IN DIABETIC MACULAR EDEMA.
    Retina. 2026 Mar 24. doi: 10.1097/IAE.0000000000004843.
    >> Share

  21. LIN CC, Cheng CK, Peng PH, Cheng SF, et al
    Real world practice of Artificial intelligence Diagnostic System for Diabetic Retinopathy in Taiwan.
    Retina. 2026 Mar 12. doi: 10.1097/IAE.0000000000004826.
    >> Share

    February 2026
  22. SCAMPOLI A, Governatori L, Solimeo A, Plaitano C, et al
    Association Between Baseline Glycated Hemoglobin Levels and Functional and Anatomical Outcomes Following Faricimab Loading Phase in Diabetic Macular Edema.
    Retina. 2026 Feb 24. doi: 10.1097/IAE.0000000000004820.
    >> Share

  23. ZHU J, Liu J, Chen YX, Yang XW, et al
    Compare Combined Use of Anti-VEGF Drugs During or After PPV for Diabetic Macular Edema Guided by MIOCT.
    Retina. 2026 Feb 3. doi: 10.1097/IAE.0000000000004801.
    >> Share

  24. BEGAR PG, Demirel S, Sermet F
    Longitudinal Quantitative Evaluation of Retinal and Choroidal Vasculature in Diabetic Patients with and without Retinopathy Using OCT, OCTA, and Semi-Automated MATLAB Method.
    Retina. 2026 Feb 3. doi: 10.1097/IAE.0000000000004802.
    >> Share

    January 2026
  25. ZHENG K, Lu P, Huang J, Chen R, et al
    Non-invasive evaluation of diabetic retinal neovascularization using 24x20 mm ultra-widefield optical coherence tomography angiography.
    Retina. 2026 Jan 30. doi: 10.1097/IAE.0000000000004790.
    >> Share

  26. SALADINO A, Arrigo A, Koutsidis C, Eduardo Stanga SF, et al
    Value of Combining Ultra-widefield Fundus Fluorescein Angiography (UWF-FFA) with 130 degrees Single-scan Ultra-widefield Optical Coherence Tomography Angiography (UWF-OCTA) in Retinal Vasculopathies.
    Retina. 2026 Jan 30. doi: 10.1097/IAE.0000000000004797.
    >> Share

    November 2025
  27. LI B, Li S, Cun Y
    The Efficacy and Safety of Subretinal Balanced Salt Solution Injection in Diabetic Macular Edema with Hard Exudates.
    Retina. 2025 Nov 26. doi: 10.1097/IAE.0000000000004742.
    >> Share

  28. MARIACRISTINA P, Eliana C, Daniele G, Monica V, et al
    DRSplus retinographer in patients with diabetes: a comparison study by consensus grading, Reading Center and Artificial Intelligence.
    Retina. 2025 Nov 12. doi: 10.1097/IAE.0000000000004734.
    >> Share

  29. SAHARE H
    Diabetic retinopathy phenotypes on ultrawide field retinal imaging in an Indian population.
    Retina. 2025 Nov 3. doi: 10.1097/IAE.0000000000004720.
    >> Share

    October 2025
  30. LIU D, Maguire MG, Jonna G, Jampol LM, et al
    Association of Patient Age with Response to Anti-Vascular Endothelial Growth Factor Agents for Treatment of Diabetic Macular Edema.
    Retina. 2025 Oct 14. doi: 10.1097/IAE.0000000000004707.
    >> Share

  31. KIRIK F, Ersoz MG, Atalay F, Akbulut E, et al
    OUTER RETINAL LAYER DETERIORATION PATTERNS IN EYES WITH DIABETIC SEROUS MACULAR DETACHMENT.
    Retina. 2025 Oct 7. doi: 10.1097/IAE.0000000000004698.
    >> Share

    September 2025
  32. LU ES, Cui Y, Phu KK, Ding X, et al
    Expanded Field OCTA Biomarkers Associated with Future Cardiovascular Disease and Mortality in Patients with Diabetic Retinopathy.
    Retina. 2025 Sep 29. doi: 10.1097/IAE.0000000000004695.
    >> Share

  33. LU ES, Lu Y, Cui Y, Zeng R, et al
    Expanded field OCTA Biomarkers Associated with the Development of Tractional Retinal Detachment in Proliferative Diabetic Retinopathy.
    Retina. 2025 Sep 3. doi: 10.1097/IAE.0000000000004661.
    >> Share

    August 2025
  34. SU T, Lai C, Du Z, Cao J, et al
    Retinal Photoreceptors and Arterioles Alterations Detected using Adaptive Optics Scanning Laser Ophthalmoscopy in Diabetes and Diabetic Retinopathy.
    Retina. 2025 Aug 21. doi: 10.1097/IAE.0000000000004647.
    >> Share

    July 2025
  35. BLINDER KJ, Wykoff CC, Ferencz JR, Ehlers JP, et al
    Impact of the Dexamethasone Implant on Slowing Diabetic Retinopathy Progression: Post Hoc Analysis of the MEAD Study.
    Retina. 2025 Jul 23. doi: 10.1097/IAE.0000000000004623.
    >> Share

  36. MCLAUGHLIN SA, Davila N, Shields C, Bineshfar N, et al
    Impact of GLP-1 receptor agonists for type 2 diabetes mellitus on the development and progression of age-related macular degeneration.
    Retina. 2025 Jul 22. doi: 10.1097/IAE.0000000000004616.
    >> Share

  37. PLOUMI I, Ding X, Romano F, Gan J, et al
    Associations Between Predominant Peripheral Lesions and Systemic Complications of Diabetes Mellitus.
    Retina. 2025 Jul 18. doi: 10.1097/IAE.0000000000004620.
    >> Share

  38. JAFFE GJ, Deak G, Gibson K, Khurana RN, et al
    IMPACT OF FARICIMAB VERSUS AFLIBERCEPT ON EPIRETINAL MEMBRANE FORMATION OVER 2 YEARS IN PATIENTS WITH DIABETIC MACULAR EDEMA IN THE PHASE 3 YOSEMITE AND RHINE TRIALS.
    Retina. 2025 Jul 14. doi: 10.1097/IAE.0000000000004572.
    >> Share

  39. SCAMPOLI A, Carla MM, Grieco G, Catalani R, et al
    EFFECTS OF FARICIMAB LOADING PHASE ON DIABETIC MACULAR EDEMA IN REAL-WORLD SETTING: An Optical Coherence Tomography Angiography Study.
    Retina. 2025;45:1313-1322.
    >> Share

    June 2025
  40. LAN T, Huang C, Tao M, Xu X, et al
    The feasibility of Ultra-widefield SS-OCTA to guide laser photocoagulation in retinal vascular diseases.
    Retina. 2025 Jun 24. doi: 10.1097/IAE.0000000000004593.
    >> Share

  41. MAHMOUD RA, Fayed AE, Estawro RG
    Topographic Patterns of Peripheral Diabetic Neovascularization on Ultrawide-Field Fluorescein Angiography.
    Retina. 2025 Jun 19. doi: 10.1097/IAE.0000000000004568.
    >> Share

  42. SINA EM, Pena J, Zafar S, Bommakanti NK, et al
    Automated Machine Learning Classification of Optical Coherence Tomography Images of Retinal Conditions Using Google Cloud Vertex AI.
    Retina. 2025 Jun 11. doi: 10.1097/IAE.0000000000004555.
    >> Share

    May 2025
  43. CASTELLANOS-CANALES D, Duffy BV, Decker NL, Yamaguchi TC, et al
    Relationship of Deep Capillary Plexus Nonperfusion to Visual Acuity and Low Light Vision in Diabetic Retinopathy through OCTA Analysis.
    Retina. 2025 May 27. doi: 10.1097/IAE.0000000000004517.
    >> Share

  44. HUANG S, Chen H, Zheng W, Lin B, et al
    Impact of Anisometropia on Diabetic Retinopathy Progression: The Role of Optical Coherence Tomography Biomarkers.
    Retina. 2025 May 14. doi: 10.1097/IAE.0000000000004532.
    >> Share

  45. ISHIBASHI T, Morimoto Y, Fukuyama S, Nakashima H, et al
    A Feasible and Reproducible Surgical Approach for Subfoveal Hard Exudates Removal via Intentional Macular Hole Creation in Diabetic Retinopathy.
    Retina. 2025 May 12. doi: 10.1097/IAE.0000000000004525.
    >> Share

  46. GILEAD N, Chong YJ, Yamaguchi TCN, Chan HH, et al
    Incidence of Visual Loss in Patients with Diabetic Macular Ischemia (DMI) A 1- year Prospective Study.
    Retina. 2025 May 6. doi: 10.1097/IAE.0000000000004483.
    >> Share

  47. CHERIAN J, Sivaprasad S, R R, Raman R, et al
    Diabetic retinopathy phenotypes on ultrawide field retinal imaging in an Indian population.
    Retina. 2025 May 5. doi: 10.1097/IAE.0000000000004510.
    >> Share

    April 2025
  48. CHEN KM, Zhao CS, Knapp A, Dow E, et al
    Targeted Interventions Lead to Quality Improvement in Year 2 of an Artificial Intelligence-Based Diabetic Retinopathy Detection Program in Northern California.
    Retina. 2025 Apr 30. doi: 10.1097/IAE.0000000000004499.
    >> Share

  49. TALEBI R, Fortes BH, Yu F, Coleman AL, et al
    Real-world Associations Between GLP-1 Receptor Agonist Use and Diabetic Retinopathy Accounting for Longitudinal Glycemic Control.
    Retina. 2025 Apr 30. doi: 10.1097/IAE.0000000000004507.
    >> Share

  50. WANG X, Wang X, Zhang W, Zhang Y, et al
    Hyperfluorescent spots in late frames of indocyanine green angiography: a new target for diabetic macular edema.
    Retina. 2025 Apr 16. doi: 10.1097/IAE.0000000000004490.
    >> Share

    March 2025
  51. MATURI JR, Boucher N, Fernando R, Scott AW, et al
    Visual outcomes and adherence challenges in proliferative diabetic retinopathy anti-VEGF monotherapy in the clinical practice setting.
    Retina. 2025 Mar 5. doi: 10.1097/IAE.0000000000004440.
    >> Share

    February 2025
  52. ZOU C, Liu W, Chang Q, Xuan Y, et al
    Application of ultrawide-field ss-OCTA in the precise diagnosis of diabetic retinopathy.
    Retina. 2025 Feb 19. doi: 10.1097/IAE.0000000000004406.
    >> Share

  53. MAROLO P, Volti GL, Nicolosi A, Avitabile T, et al
    Combined Intravitreal Aflibercept and Anti-inflammatory Oral Supplementation in the Treatment of Diabetic Macular Edema: Two-Year Randomized Controlled Trial Results.
    Retina. 2025 Feb 12. doi: 10.1097/IAE.0000000000004427.
    >> Share

  54. HUANG RS, Mihalache A, Popovic MM, Munn C, et al
    Quantitative Fluorescein Angiography Biomarkers in Diabetic Macular Edema.
    Retina. 2025 Feb 5. doi: 10.1097/IAE.0000000000004424.
    >> Share

    January 2025
  55. MEDURI A, De Luca L, Oliverio GW, Mancini M, et al
    Dexamethasone Intravitreal Injection in Diabetic Patients Undergoing Cataract Surgery: an updated literature review.
    Retina. 2025 Jan 3. doi: 10.1097/IAE.0000000000004381.
    >> Share

  56. MONTESEL A, Sen S, Preston E, Patel PJ, et al
    Intraocular Inflammation (IOI) Associated with Faricimab Therapy: One-year Real World Outcomes.
    Retina. 2025 Jan 2. doi: 10.1097/IAE.0000000000004394.
    >> Share

    December 2024
  57. VIDAL-OLIVER L, Spissinger S, Almeida EH, Garzone D, et al
    Prevalence and associated factors of choroidal caverns in patients with type 2 diabetes mellitus.
    Retina. 2024 Dec 3. doi: 10.1097/IAE.0000000000004365.
    >> Share

    November 2024
  58. CAPOROSSI T, Crincoli E, Culiersi C, Scampoli A, et al
    Decreasing outer retina traumatism of ILM peeling in diabetic eyes with foveal sparing technique.
    Retina. 2024 Nov 20. doi: 10.1097/IAE.0000000000004350.
    >> Share

  59. RAJAGOPAL R, McGill JB
    NOVEL AGENTS IN THE MANAGEMENT OF DIABETES AND RISK OF WORSENING DIABETIC RETINOPATHY.
    Retina. 2024;44:1851-1859.
    >> Share

  60. SCHILDROTH KR, Peterson KD, Altaweel MM, Channa R, et al
    SUPPLEMENTAL DEXTROSE IN THE INFUSION FLUID DURING DIABETIC VITRECTOMY.
    Retina. 2024;44:1931-1936.
    >> Share

    October 2024
  61. SHIMURA M, Hirano T, Tsuiki E, Takamura Y, et al
    Alteration of treatment choices and the visual prognosis for diabetic macular edema in the era of anti-VEGF drugs: Analysis of the STREAT-DME 2 study.
    Retina. 2024 Oct 15. doi: 10.1097/IAE.0000000000004301.
    >> Share

  62. RAHMAN NA, Chellapan K, Ong PY, Adnan A, et al
    COMPARING STAGES OF DIABETIC RETINOPATHY WITH SYSTEMIC VASCULAR STATUS USING FINGER PHOTOPLETHYSMOGRAPHY.
    Retina. 2024 Oct 15. doi: 10.1097/IAE.0000000000004297.
    >> Share

  63. MBAYE S, Aw A, Malick Sy EH, Mbara Ka A, et al
    Assessment of Artificial Intelligence software for automatic screening of Diabetic Retinopathy based on fundus photographs in Melanoderm subjects.
    Retina. 2024 Oct 15. doi: 10.1097/IAE.0000000000004310.
    >> Share

  64. HE X, Deng X, Lin Z, Wen L, et al
    Screening and monitoring of diabetic retinopathy in community care: the effectiveness of single-field vs multi-field fundus photography.
    Retina. 2024 Oct 15. doi: 10.1097/IAE.0000000000004311.
    >> Share

    September 2024
  65. HWANG Y, Takahashi H, Won J, Yaghy A, et al
    Quantification of capillary blood flow speeds in diabetic retinopathy using variable interscan time analysis (VISTA) OCTA.
    Retina. 2024 Sep 25. doi: 10.1097/IAE.0000000000004279.
    >> Share

  66. SILVA PS, Liu D, Aiello LP, Melia M, et al
    Diabetic Retinopathy Lesion Types and Distribution on Ultrawide Field Imaging and the Risk of Disease Worsening Over Time.
    Retina. 2024 Sep 12. doi: 10.1097/IAE.0000000000004263.
    >> Share

  67. ROHOWETZ LJ, Shaheen A, Magraner M, Flynn HW Jr, et al
    SURGICAL OUTCOMES IN CONCURRENT SICKLE CELL AND DIABETIC RETINOPATHY.
    Retina. 2024;44:1560-1564.
    >> Share

    August 2024
  68. TORRES-VILLAROS H, Timoumi R, Fajnkuchen F, Klokner A, et al
    Macular thickness fluctuations and visual acuity outcomes after intravitreal dexamethasone implant for diabetic macular edema.
    Retina. 2024 Aug 28. doi: 10.1097/IAE.0000000000004213.
    >> Share

  69. RAJAGOPAL R, McGill JB
    Novel Agents in the Management of Diabetes and Risk of Worsening Diabetic Retinopathy.
    Retina. 2024 Aug 14. doi: 10.1097/IAE.0000000000004252.
    >> Share

  70. LEE MW, Jun JH, Yu HY, Kim JT, et al
    SUPERFICIAL AND DEEP VASCULAR COMPLEXES DAMAGED TO DIFFERENT EXTENTS IN ADVANCED STAGES OF DIABETIC RETINOPATHY.
    Retina. 2024;44:1298-1304.
    >> Share

  71. LI Z, Yang F, Deng X, Yang Y, et al
    ASSOCIATIONS BETWEEN CHOROIDAL ALTERATIONS AND EARLY NEURODEGENERATION IN DIABETES WITHOUT DIABETIC RETINOPATHY: Insights From Ultra-Widefield Optical Coherence Tomography Angiography Imaging.
    Retina. 2024;44:1288-1297.
    >> Share

  72. CASTELLANOS-CANALES D, Decker NL, Fukuyama H, Duffy BV, et al
    RELIABILITY OF CLINICAL GRADING OF DIABETIC RETINOPATHY COMPARED WITH GRADING OF ULTRA-WIDEFIELD IMAGES.
    Retina. 2024;44:1279-1287.
    >> Share

    July 2024
  73. ISHIKAWA K, Nakao S, Mori K, Fukuda Y, et al
    Fluid aspiration from intraretinal cysts for refractory diabetic macular edema.
    Retina. 2024 Jul 3. doi: 10.1097/IAE.0000000000004198.
    >> Share

    June 2024
  74. FICKWEILER W, Chokshi T, Jangolla S, Mitzner M, et al
    CLINICAL CHARACTERIZATION OF AQUEOUS AND VITREOUS RETINOL-BINDING PROTEIN 3 CONCENTRATIONS IN RELATION TO DIABETIC RETINOPATHY SEVERITY, RETINAL STRUCTURES, AND SYSTEMIC COMPLICATIONS.
    Retina. 2024;44:1026-1033.
    >> Share

  75. WANG M, Shao Y, Gong Y, Liu B, et al
    ASSOCIATION OF MACULAR STRUCTURE WITH MICROPERIMETRY SENSITIVITY FOLLOWING VITRECTOMY FOR PROLIFERATE DIABETIC RETINOPATHY.
    Retina. 2024;44:982-990.
    >> Share

    May 2024

  76. LESS IS MORE: Reducing Injections and Optimizing Vision With Anti-VEGF Therapy for nAMD, DR, and DME.
    Retina. 2024;44.
    >> Share

    April 2024
  77. SU T, Lai D, Wu Y, Gu C, et al
    COMPARISON OF THE EFFICACY AND SAFETY OF RANIBIZUMAB 0.5 MG VERSUS 1.0 MG WITH PARS PLANA VITRECTOMY FOR THE TREATMENT OF PROLIFERATIVE DIABETIC RETINOPATHY: A Randomized Controlled Trial.
    Retina. 2024;44:680-688.
    >> Share

    March 2024
  78. ZENG Y, Wen F, Zhuang X, He G, et al
    Epiretinal Macrophage-like Cells on Optical Coherence Tomography: Potential Inflammatory Imaging Biomarker of Severity in Diabetic Retinopathy.
    Retina. 2024 Mar 12. doi: 10.1097/IAE.0000000000004100.
    >> Share

  79. BALAS M, Issa M, Popovic MM, Moayad L, et al
    Adaptive Optics Imaging in Diabetic Retinopathy: A Prospective Cohort Study.
    Retina. 2024 Mar 12. doi: 10.1097/IAE.0000000000004088.
    >> Share

  80. ZUR D, Hod K, Trivizki O, Rabinovitch D, et al
    Anti-Vascular Endothelial Growth Factor Treatment in Diabetic Macular Edema-Results from a Large Single Center Cohort with Bevacizumab As First-Line Therapy.
    Retina. 2024 Mar 12. doi: 10.1097/IAE.0000000000004096.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016